EcoDrugPlus

Ensembl ID : ENSODEG00000019613
Gene Symbol: -
Cross references: -
113 Possible Orthologues:

Ensembl ID : ENSODEG00000020368
Gene Symbol: -
Cross references: -
134 Possible Orthologues:

Ensembl ID : ENSODEG00000006804
Gene Symbol: -
Cross references: -
146 Possible Orthologues:

Ensembl ID : ENSODEG00000001767
Gene Symbol: -
Cross references: -
129 Possible Orthologues:

Ensembl ID : ENSODEG00000001825
Gene Symbol: -
Cross references: -
129 Possible Orthologues:

Ensembl ID : ENSODEG00000013772
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSODEG00000004069
Gene Symbol: -
Cross references: -
72 Possible Orthologues:

Ensembl ID : ENSODEG00000007939
Gene Symbol: -
Cross references: -
166 Possible Orthologues:

Ensembl ID : ENSODEG00000013585
Gene Symbol: -
Cross references: -
168 Possible Orthologues:

Ensembl ID : ENSODEG00000019468
Gene Symbol: -
Cross references: -
164 Possible Orthologues:

Ensembl ID : ENSODEG00000019832
Gene Symbol: -
Cross references: -
168 Possible Orthologues:

Ensembl ID : ENSODEG00000010570
Gene Symbol: -
Cross references: -
153 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).